Status:
ACTIVE_NOT_RECRUITING
Analysis of the Levels of HLADR+ Extracellular Vesicles in Women With Preeclampsia as a Early Potential Biomarker
Lead Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions:
Preeclampsia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Analysis of the circulating levels of placenta-derived HLA-DR+ extracellular vesicles in the first, second and third trimester of pregnancy of women with high and low risk to develop preeclampsia.
Detailed Description
The aim of this study is to analyze the levels of circulating placenta-derived HLA-DR+ extracellular vesicles in the first, second and third trimester of pregnancy of women with high and low risk to d...
Eligibility Criteria
Inclusion
- Pregnant Women
- Aged \> 18 years
Exclusion
- age \< 18 years
- women unable to give informed consent
- infectious diseases
- twin pregnancies
Key Trial Info
Start Date :
September 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06873737
Start Date
September 1 2022
End Date
January 1 2026
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Fondazione Policlinico Universitario Agostino Gemelli
Rome, Italy, 00168